Ryan Halsted
Stock Analyst at RBC Capital
(1.28)
# 3,932
Out of 5,152 analysts
11
Total ratings
57.14%
Success rate
-7.04%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Initiates: Outperform | $522 | $469.38 | +11.21% | 1 | Mar 3, 2026 | |
| IQV IQVIA Holdings | Initiates: Outperform | $221 | $178.50 | +23.81% | 1 | Mar 3, 2026 | |
| HCSG Healthcare Services Group | Initiates: Sector Perform | $22 | $20.98 | +4.86% | 1 | Mar 3, 2026 | |
| MDLN Medline | Maintains: Outperform | $47 → $53 | $44.05 | +20.32% | 2 | Feb 26, 2026 | |
| EVH Evolent Health | Maintains: Sector Perform | $5 → $3 | $3.40 | -11.76% | 1 | Feb 25, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $23.84 | +30.03% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $18.88 | +21.82% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $207.30 | - | 3 | Apr 28, 2017 |
Medpace Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $522
Current: $469.38
Upside: +11.21%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $178.50
Upside: +23.81%
Healthcare Services Group
Mar 3, 2026
Initiates: Sector Perform
Price Target: $22
Current: $20.98
Upside: +4.86%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47 → $53
Current: $44.05
Upside: +20.32%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5 → $3
Current: $3.40
Upside: -11.76%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $23.84
Upside: +30.03%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $18.88
Upside: +21.82%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $207.30
Upside: -